← Back to News List

Macrophage cell therapy boosts four-year transplant-free survival in advanced cirrhosis

MedicalXpress | ماي 25, 2026
News Cover

A new type of cell therapy shows promise as the first treatment for advanced liver disease, following results from a clinical trial. Patients with the condition who were treated with the cell therapy had a significantly lower risk of death or need for a liver transplant after four years compared with those who received standard medical care.

This article was originally published by MedicalXpress. For more details, images, and references:

Read Full Original Article ↗